# Symptoms and Physical Activity in COPD Patients in Europe

> **NCT03031769** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 2176 (actual)

## Conditions studied

- COPD

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03031769
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-21
- **Primary completion:** 2017-08-31
- **Final completion:** 2017-08-31
- **Target enrollment:** 2176 (ACTUAL)
- **Last updated:** 2017-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03031769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03031769, "Symptoms and Physical Activity in COPD Patients in Europe". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03031769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*